31 Jan , 2025 By : Debdeep Gupta
Bharat Electronics
Nomura On BEL
Buy Call, Target At `363/Sh
Significant Operational Beat In Q3
FY25 Earnings Up 8%; Expect Heavy Ordering In Q4
Management Remains Conservative With No Change In Guidance For Sales/Margin
Raise FY25 EBITDA Margin/EPS By 200 bps/8% To Reflect Significant Beat In Q3
Stock Currently Trades At 30x FY27 EPS
Jefferies On BEL
Buy Call, Target At `370/Sh
Q3 EBITDA Was 51?ove Expectations, As Margin Rose To 28.7% Vs Expected 23.7%
Co Tends To See Quarterly Revenue & Margin Volatility Based On Deliveries
Management Retaining Vs Raising Guidance, Maintain Estimates
Margin Strength Gives Confidence In Profitability Sustaining
PB Fintech
HSBC On PB Fin
Buy Call, Target At `2,530/Sh
Co Reported Robust Premium Growth & EBITDA Margin Expansion In Q3
Core-Operating Performance Was In-line
Medium-term Outlook On Business Growth & Profitability Remains Healthy
Est FY25-28 CAGR Of 27% In Revenue, EBITDA Margin Of 18% & Profit Margin Of 17% By FY28
MS On PB Fin
Underweight Call, Target At `1,400/Sh
Adjusted EBITDA Was line in Q3
Cut FY25 Forecast & Expect Consensus To Do So Also
Core New Premium Growth Slowed More Than Expected, From Slower Savings
Steep Valuation Keeps Us Underweight
Bank Of Baroda
Jefferies On Bank Of Baroda
Hold Call, Target Cut To `250/Sh
For Q3, Profit Was Ahead Of Estimates Aided By Lower Provisions
While Loan Growth Of 12% Was Healthy, NII Growth Of 3% Was Softened By Margin Fall
Feel Bank's Higher Domestic LDR Might Limit Loan Growth As Domestic Deposit Growth Is Softer
Asset Quality Stays Stable With Low Credit Cost
HSBC On Bank Of Baroda
Hold Call, Target Cut To `250/Sh
Q3 Core Fee Income And QoQ Improvement In Credit Costs Offset Pressure In NIM
Asset Quality Was Healthy
Change EPS Estimates By 4/-2.6/-3.6% For FY25/26/27 Respectively
Cut Is To Build In Further Pressure On NIM
EPS Growth Outlook Remains Muted
Jefferies On Adani PortsBuy Call, Target At `1,440/Sh
Q3 EBITDA 4?ove Estimates Driven By Higher SEZ Income
Management Maintained Their 10-14% YoY Volume Growth Guidance For FY25
10-14% YoY Volume Growth Guidance For FY25 Implies 17-35% YoY Rise In Q4
EBITDA Guidance Was Raised & Was Above Estimates
Logistics Potential Is A Sweetener
Nomura On Tata Consumer
Buy Call, Target At `1,250/Sh
Strong Delivery In Core; High Volume Growth In Tea, Strong Price Hike To Boost Overall Growth
Growth Business Growing 89% YoY On A Strong Wicket
OPM To Improve Going Forward On The Back Of Price Hikes
Stock Trades At 46x FY27 EPS
Nomura On Dabur
Buy Call, Target At `625/Sh
Q3 Was In-line With Expectations
Growth To Gradual Improve As Rural Improves & Urban Is Near Bottoming Out
Gradual Pickup In Sales Is Expected
HPC Sales 5.7%; Healthcare -1.3% While Beverages Was -10.3%
Margin To Also Improve Gradually
Nomura On Dr LalPath Labs
Upgrade To Buy, Target At `3,315/Sh
Q3 Revenue In-line But EBITDA/Profit Below Estimates
Co Now Intends To Focus On Expanding Its Presence In Southern India
Co Has Not Undertaken Any Price Increases In the Recent Past & Does Not Intend To Do So In the Near Future
Recent Stock Correction Presents Limited Downside Risk
Nomura On GAIL
Buy Call, Target At `240/Sh
Results Sharply Miss Estimates On Lower Gas Marketing & Petchem Profitability
Gas Transmission EBIT Was 4?low Estimates & Declined 2% QoQ
Adjusted Gas Marketing EBIT Was Sharply Below Estimate
LPG/LHC Segment EBIT Was Below Estimates
Trades At Attractive Valuations Of 10x FY27 P/E
Nuvama On SRF
Buy Call, Target At `2,929/Sh
Q3 Earnings Led By Revived Momentum In Chemicals Biz After 6 Quarters Of Disappointment
EBITDA Beat Estimate By 6.3%, Largely Led By Margin Expansion In Chemicals Business To 24.3%
Packaging Films Reported A Stable Performance In A Tough Scenario
Likely Margin Improvements In Chemicals Biz Due To Better Ref-Gas Prices, Which Now Seems Sustainable
HSBC On RR Kabel
Upgrade To Buy, Target At `1,600/Sh
After An Unexciting CY24, Co Looks Set To Return To A Strong Profit Growth Trajectory
Co’s Profit Growth Trajectory Is Materially Above Peers
Strong Profit Growth Outlook And Attractive Valuations Makes Us Constructive At Current Prices
Expect FY25-27 Revenue & EPS CAGR Of 18% And 46%, Respectively
0 Comment